Patent: 8,435,518
✉ Email this page to a colleague
Summary for Patent: 8,435,518
Title: | Methods of using IL-17 receptor a antibodies |
Abstract: | The present invention relates to IL-17 Receptor A antigen binding proteins, such as antibodies, and methods for diagnosing and treating diseases mediated by IL-17 Receptor A activation. |
Inventor(s): | Tocker Joel, Peschon Jacques J., Fitzpatrick David |
Assignee: | Kirin-Amgen, Inc. |
Application Number: | US12899290 |
Patent Claims: | see list of patent claims |
Details for Patent 8,435,518
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Valeant Pharmaceuticals Luxembourg S.à.r.l. | SILIQ | brodalumab | Injection | 761032 | February 15, 2017 | ⤷ Sign Up | 2030-10-06 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |